Online Program Home
  My Program

Abstract Details

Activity Number: 151 - Enrichment Clinical Trials: Novel Designs, Statistical Inferences, and Case Studies
Type: Topic Contributed
Date/Time: Monday, July 31, 2017 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #323935
Title: Assessment of Utility of Total Kidney Volume for Trial Enrichment
Author(s): John Lawrence*
Companies:
Keywords: chronic kidney disease ; mixed effects models ; renal disease ; measurements errors ; counting process
Abstract:

A consortium recently submitted an application to qualify Total Kidney Volume (TKV) as a biomarker for enriching trials of patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). TKV, in combination with patient age and baseline estimated glomerular filtration rate (eGFR), was qualified as a prognostic enrichment biomarker for ADPKD subjects at high risk for a progressive decline in renal function, defined as a confirmed 30% decline in eGFR. Risk scores can be derived from datasets to select patients to enrich future trials. The utility of this approach is discussed. We used a model from the historical datasets to define a risk score and applied it to a hypothetical trial. In the hypothetical trial, we simulated data according to a model that was fit to an independent dataset. We found the risk score may not select the higher risk patients very well. The R package SurvDisc can be used to try out different assumptions and enrichment criteria. This will be illustrated in the presentation.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2017 program

 
 
Copyright © American Statistical Association